Between the Hospital and Home: End of Life in Pediatric Oncology

Background: Children with complex oncological disease and palliative care needs benefit from coordinated care across hospital, community and family settings. Before 2021, palliative care was already provided through hospital resources, without a dedicated team. In 2021, a hospital-based Paediatric Palliative Care Team (EIHCPP) was established, providing a more structured framework with members from the paediatric oncology service (physicians and nurses) dedicating part of their working hours to the team. We aimed to characterise the evolution of hospital–community care integration and the resources involved in end-of-life care.

Methods: Retrospective descriptive study of 64 children and adolescents with cancer followed at a Pediatric Oncology Department who died between 2016 and 2025. Demographic and clinical characteristics, distance from home to hospital, involvement of the EIHCPP, Integrated Continuing Care Teams (ECCI), Community Palliative Care Teams (ECSCP), Home Hospitalisation Medical Team (UMAD), local case-management physicians, psychological support and timing of intervention were analysed. Resource involvement was descriptively compared between 2016–2020 and 2021–2025.

Results: Sixty-four children were included, with a median age at diagnosis of 6 years (IQR 3–11.25); 50% were female and 71.9% had central nervous system tumours. Among children who died from 2021 onwards, 32/38 (84.2%) received EIHCPP support. Community-based resources were increasingly involved, with ECCI supporting 14/38 (36.8%) and ECSCP 14/38 (36.8%), while UMAD support from our hospital decreased from 16/26 (61.5%) to 7/38 (18.4%). Psychological support increased for both children (3/26 [11.5%] vs. 17/38 [44.7%]) and families (0 vs. 18/38 [47.4%]). Identification and involvement of a case-management physician from the hospital in the child’s local area of residence increased from 1/26 (3.8%) to 10/38 (26.3%). Information on the child’s condition and care needs was shared with the family physician to support continuity of care. Care was also adapted to family resources, including a case in which a nurse relative provided care in direct coordination with the EIHCPP team. Six children received local ECCI and/or ECSCP support without physical involvement from our hospital; median distance from their home to our hospital was 75 km; a single hypothetical round trip by the hospital team to each of these children would represent 1,176 km of potential travel. Before the team, 38.5% died at home, 57.7% at the referral hospital, and 3.8% in intensive care; after its establishment, 36.8% died at home, 50.0% at the referral hospital, and 13.2% at a hospital in the area of residence.

Conclusions: Establishment of a dedicated paediatric palliative care team was associated with greater structuring and diversification of an already existing palliative care network. The involvement of community teams, local professionals, psychological support and family resources illustrates a flexible, integrated model extending care beyond the hospital, in line with patients' and families' wish to remain at home for as long as possible. Such collaboration may facilitate care closer to home and reduce the need for hospital-team travel, particularly for geographically distant families.